Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Virginia Commonwealth University
OBJECTIVES:
* To acquire experience in the marker implantation process for mediastinal lymph nodes and primary lung tumors in patients with stage I-IIIB non-small cell lung cancer.
* To characterize the potential side effects involved in the use of markers in these patients.
* To analyze the positional stability of lung markers in these patients over a radiotherapy series.
* To acquire experience in the use of markers for treatment planning and radiotherapy in these patients.
OUTLINE: Patients undergo implantation of ≥ 1 small radio-opaque Visicoil™ marker into or close to the primary lesion and affected lymph nodes by bronchoscopy. Patients then undergo x-rays to document marker location, detect potentially dropped markers, and diagnose operation-related side effects (i.e., pneumothorax). After marker implantation, patients undergo stereotactic or conventionally fractionated radiotherapy for 30-33 daily fractions.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
DISEASE CHARACTERISTICS:
Diagnosis of non-small cell lung cancer
* Stage I-IIIB disease
No prior surgical tumor resection
Respiration-induced tumor motion \> 5 mm
Recruited by attending physician or research nurse at the Medical College of Virginia Hospitals
PATIENT CHARACTERISTICS:
Not pregnant
No insufficient lung function or other parameters prohibiting a bronchoscopy